Target Name: LOC105376219
NCBI ID: G105376219
Other Name(s): uncharacterized LOC105376219 | Uncharacterized LOC105376219, transcript variant X2 | LOC105376219 variant X2

LOC105376219: A Potential Drug Target and Biomarker

LOC105376219 is a protein that has not yet been characterized, but it holds great potential as a drug target and biomarker. Its unique structure and various biochemical properties make it an interesting candidate for further research. This article will discuss the potential implications of LOC105376219 as a drug target and biomarker, as well as its potential clinical applications.

Potential Drug Target

LOC105376219 is a protein that is expressed in various tissues and cells of the body. It has been shown to play a role in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs. LOC105376219 has been shown to interact with several other proteins, including the protein known as E-cadherin.

E-cadherin is a transmembrane protein that is involved in cell-cell adhesion. It helps to maintain the integrity of tissues and is a key factor in the development and progression of many diseases, including cancer.

Research has shown that LOC105376219 can interact with E-cadherin, which could imply that it has potential as a drug target. By targeting LOC105376219, researchers could potentially disrupt its interactions with E-cadherin and improve the growth and development of cancer cells.

Potential Biomarker

LOC105376219 has also been shown to be expressed in various types of cancer cells, which could make it an attractive biomarker for cancer diagnostics and treatment. Cancer is a leading cause of death worldwide, and early detection and treatment are crucial for improving survival rates.

Research has shown that LOC105376219 can be used as a biomarker for various types of cancer, including breast, ovarian, and prostate cancers. This suggests that LOC105376219 could be a valuable tool for cancer diagnosis and treatment, particularly in the development of more targeted therapies.

Conclusion

LOC105376219 is an interesting protein that has not yet been fully characterized. However, its unique structure and interactions with other proteins make it a promising candidate as a drug target and biomarker. Further research is needed to determine its full potential as a drug and to explore its potential clinical applications in the treatment of cancer.

Protein Name: Uncharacterized LOC105376219

More Common Targets

LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276